People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Stemina Biomarker Discovery, Inc. | — | Biotechnology | Series A | $7.9M | $36.2M | 2016 |
Kevin L.R. Krenitsky at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kevin L.R. Krenitsky on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| R Andrew Morgan | 1 | 2 |
| Elizabeth L.R. Donley | 1 | 2 |
| Judith K. Marquis | 1 | 1 |
| Marc Andrew Schneebaum | 1 | 1 |
| Andrew E. Ferrara | 1 | 1 |
| Robert E. Burrier | 1 | 1 |
| Scott E. Carr | 1 | 1 |
| Kevin E. Krenitsky | 1 | 1 |
| Scott L.R. Carr | 1 | 1 |
| Andrew L.R. Ferrara | 1 | 1 |
| Robert Andrew Burrier | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.